著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
H Kawaguchi and T Yamashita and N Masuda and M Kitada and K Narui and M Hattori and T Yoshinami and N Matsunami and K Yanagihara and T Kawasoe and T Nagashima and H Bando and H Yano and Y Hasegawa and R Nakamura and M Kashiwaba and S Morita and S Ohno and M Toi,Abstract P5-21-07: Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer,Cancer Research,0008-5472,American Association for Cancer Research (AACR),2018-02-15,78,4_Supplement,,https://cir.nii.ac.jp/crid/1360011144177642112,https://doi.org/10.1158/1538-7445.sabcs17-p5-21-07